Needham Starts Cogent with Buy Rating

Analyst Joseph Craigen says the biometrics company is well-positioned for opportunities

Needham & Company initiates coverage of biometrics-company Cogent (COGT ) with a buy rating.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.